114 related articles for article (PubMed ID: 8149989)
1. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Yan QS; Jobe PC; Dailey JW
Eur J Pharmacol; 1994 Jan; 252(1):105-12. PubMed ID: 8149989
[TBL] [Abstract][Full Text] [Related]
2. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Yan QS; Jobe PC; Cheong JH; Ko KH; Dailey JW
Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):149-52. PubMed ID: 7527501
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).
Dailey JW; Yan QS; Adams-Curtis LE; Ryu JR; Ko KH; Mishra PK; Jobe PC
Life Sci; 1996; 58(4):259-66. PubMed ID: 8538363
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
Mishra PK; Kahle EH; Bettendorf AF; Dailey JW; Jobe PC
Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
[TBL] [Abstract][Full Text] [Related]
5. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
Dailey JW; Yan QS; Mishra PK; Burger RL; Jobe PC
J Pharmacol Exp Ther; 1992 Feb; 260(2):533-40. PubMed ID: 1738103
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study.
Yan QS; Dailey JW; Steenbergen JL; Jobe PC
Brain Res; 1998 Jan; 780(2):199-209. PubMed ID: 9507130
[TBL] [Abstract][Full Text] [Related]
7. Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis.
Yan QS; Jobe PC; Dailey JW
Brain Res; 1993 Apr; 610(1):24-31. PubMed ID: 8518928
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships.
Dailey JW; Reith ME; Yan QS; Li MY; Jobe PC
Neurosci Lett; 1997 May; 227(1):13-6. PubMed ID: 9178847
[TBL] [Abstract][Full Text] [Related]
9. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
Yan QS; Mishra PK; Burger RL; Bettendorf AF; Jobe PC; Dailey JW
J Pharmacol Exp Ther; 1992 May; 261(2):652-9. PubMed ID: 1374472
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.
Browning RA; Wood AV; Merrill MA; Dailey JW; Jobe PC
Eur J Pharmacol; 1997 Oct; 336(1):1-6. PubMed ID: 9384247
[TBL] [Abstract][Full Text] [Related]
11. Neither intranigral fluoxetine nor 5,7-dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats.
Statnick M; Dailey J; Jobe P; Browning R
Eur J Pharmacol; 1996 Mar; 299(1-3):93-102. PubMed ID: 8901011
[TBL] [Abstract][Full Text] [Related]
12. Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model.
Merrill MA; Clough RW; Jobe PC; Browning RA
Epilepsia; 2005 Sep; 46(9):1380-8. PubMed ID: 16146432
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats.
Graumlich JF; McLaughlin RG; Birkhahn D; Shah N; Burk A; Jobe PC; Dailey JW
Eur J Pharmacol; 1999 Mar; 369(3):305-11. PubMed ID: 10225367
[TBL] [Abstract][Full Text] [Related]
14. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats.
Yan QS; Jobe PC; Dailey JW
Br J Pharmacol; 1995 Aug; 115(7):1314-8. PubMed ID: 7582562
[TBL] [Abstract][Full Text] [Related]
15. Localization of the serotonergic terminal fields modulating seizures in the genetically epilepsy-prone rat.
Merrill MA; Clough RW; Dailey JW; Jobe PC; Browning RA
Epilepsy Res; 2007 Sep; 76(2-3):93-102. PubMed ID: 17689928
[TBL] [Abstract][Full Text] [Related]
16. Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat.
Yan QS; Jobe PC; Dailey JW
Epilepsy Res; 1993 Mar; 14(3):229-36. PubMed ID: 8504793
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
Life Sci; 1992; 50(4):319-26. PubMed ID: 1732702
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response.
Dailey JW; Cheong JH; Ko KH; Adams-Curtis LE; Jobe PC
Neurosci Lett; 1995 Aug; 195(2):77-80. PubMed ID: 7478272
[TBL] [Abstract][Full Text] [Related]
19. The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs.
Reigel CE; Dailey JW; Jobe PC
Life Sci; 1986 Sep; 39(9):763-74. PubMed ID: 3747727
[TBL] [Abstract][Full Text] [Related]
20. Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats.
Seo DO; Shin CY; Ryu JR; Cheong JH; Choi CR; Dailey JW; Reith ME; Jobe PC; Ko KH
Eur J Pharmacol; 2000 May; 396(2-3):53-8. PubMed ID: 10822056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
